1-4 of 4
Authors: M Cozijnsen
Journal Article
P448 Long term effectiveness of first-line infliximab treatment compared to conventional treatment in paediatric moderate-to-severe Crohn’s disease – an update from the TISKids study Free
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i579–i580, https://doi.org/10.1093/ecco-jcc/jjac190.0578
Published: 30 January 2023
Journal Article
DOP67 First-line infliximab is cost-effective compared to conventional treatment in paediatric Crohn’s Disease – Results from the TISKids study Free
Journal of Crohn's and Colitis, Volume 16, Issue Supplement_1, January 2022, Pages i111–i112, https://doi.org/10.1093/ecco-jcc/jjab232.106
Published: 21 January 2022
Journal Article
OP38 Top-down infliximab superior to step-up in children with Moderate-to-Severe Crohn’s disease: A multicentre randomised controlled trial Free
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S039, https://doi.org/10.1093/ecco-jcc/jjz203.037
Published: 15 January 2020
Journal Article
P570 Adalimumab maintenance therapy in infliximab exposed pediatric Crohn's disease; a Dutch nationwide survey Get access
Journal of Crohn's and Colitis, Volume 8, Issue Supplement_1, February 2014, Pages S305–S306, https://doi.org/10.1016/S1873-9946(14)60690-5
Published: 01 February 2014
